Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotypes, phenotypes and treatment with immunomodulators in the rheumatic diseases.

Journal of internal medicine - 1 Sept 2018

van Vollenhoven R F

Abstract excerpt

The autoimmune rheumatological diseases rheumatoid arthritis (RA), spondyloarthritis (SpA) and systemic lupus erythematosus (SLE) are treated with conventional immunosuppressive agents and with modern biological immunomodulators. The latter group of medications have brought about a major change in our ability to control RA and SpA, with more modest results for SLE. The biologicals are very specific in their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arthritis, Rheumatoid
Share to Biological Products
Share to Biomarkers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunologic Factors

Share to Lupus Erythematosus, Systemic

Share to Rheumatic Diseases

Share to Spondylitis, Ankylosing

Share to Treatment Outcome

Source

Identifiers

PMID: 29908080
DOI: 10.1111/joim.12800

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotypes, phenotypes and treatment with immunomodulators in the rheumatic diseases.PMID 29908080Read ↗

Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.Semantic proximity Read ↗

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and PharmacogeneticsSemantic proximity Read ↗

Genomics and epigenomics in rheumatic diseases: what do they provide in terms of diagnosis and disease management?Semantic proximity Read ↗

Autoimmune Rheumatic Diseases — Problems of Immunopathology and Personalized TreatmentSemantic proximity Read ↗

Pharmacogenetics in treatment of rheumatoid arthritis.Semantic proximity Read ↗

Genetic Polymorphisms in Systemic Lupus Erythematosus and Their Clinical Implications: A Narrative Review.Semantic proximity Read ↗

Disease mechanisms in rheumatology--tools and pathways: defining functional genetic variants in autoimmune diseases.Semantic proximity Read ↗

Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus.Semantic proximity Read ↗

Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 TreatmentSemantic proximity Read ↗

Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.Semantic proximity Read ↗

Precision medicine in autoimmune diseases: fact or fictionSemantic proximity Read ↗

The disease formerly known as rheumatoid arthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.